AN2 Therapeutics Inc (ANTX)
2.39
-0.01
(-0.42%)
USD |
NASDAQ |
May 01, 16:00
2.48
+0.09
(+3.77%)
After-Hours: 07:57
AN2 Therapeutics Revenue (TTM)
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Revenue (TTM) Benchmarks
Gilead Sciences Inc | 27.45B |
QuidelOrtho Corp | 2.998B |
CymaBay Therapeutics Inc (DELISTED) | -- |
Insmed Inc | 305.21M |
Revance Therapeutics Inc | 234.04M |